Hybrid immunity and strategies for COVID-19 vaccination
- PMID: 36152670
- PMCID: PMC9761779
- DOI: 10.1016/S1473-3099(22)00640-5
Hybrid immunity and strategies for COVID-19 vaccination
Conflict of interest statement
I declare no competing interests.
Comment on
-
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.Lancet Infect Dis. 2023 Jan;23(1):45-55. doi: 10.1016/S1473-3099(22)00578-3. Epub 2022 Sep 21. Lancet Infect Dis. 2023. PMID: 36152671 Free PMC article.
References
-
- WHO Weekly epidemiological update on COVID-19. Aug 31, 2022. https://www.who.int/publications/m/item/weekly-epidemiological-update-on...
-
- WHO Interim statement on hybrid immunity and increasing population seroprevalence rates. June 1, 2022. https://www.who.int/news/item/01-06-2022-interim-statement-on-hybrid-imm...
-
- Carazo S, Skowronski DM, Brisson M, et al. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00578-3. published online Sept 21. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical